Feedback / Questions
Undisclosed GLP-1R, GIPR, GCGR agonist - Septerna
https://www.fiercebiotech.com/biotech/novo-nordisk-inks-22b-deal-septernas-preclinical-obesity-programs
May 14, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next